Improving Aztreonam Stewardship and Cost Through a Penicillin Allergy Testing Clinical Guideline.

ABSTRACT:

Background

Patients reporting penicillin allergy often receive unnecessary and costly broad-spectrum alternatives such as aztreonam with negative consequences. Penicillin allergy testing improves antimicrobial therapy but is not broadly used in hospitals due to insufficient testing resources and short-term expenses. We describe a clinical decision support (CDS) tool promoting pharmacist-administered penicillin allergy testing in patients receiving aztreonam and its benefits toward antimicrobial stewardship and costs.

Methods

A CDS tool was incorporated into the electronic medical record, directing providers to order penicillin allergy testing for patients receiving aztreonam. An allergy-trained pharmacist reviewed orders placed through this new guideline and performed skin t

SUBMITTER: Chen JR 

PROVIDER: S-EPMC6016425 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature